J Menkiszak
Overview
Explore the profile of J Menkiszak including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
215
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Millstein J, Budden T, Goode E, Anglesio M, Talhouk A, Intermaggio M, et al.
Ann Oncol
. 2020 May;
31(9):1240-1250.
PMID: 32473302
Background: Median overall survival (OS) for women with high-grade serous ovarian cancer (HGSOC) is ∼4 years, yet survival varies widely between patients. There are no well-established, gene expression signatures associated...
2.
Menkiszak J, Sopik V, Chudecka-Glaz A, Domagala W, Urasinska E, Symonowicz H, et al.
Clin Genet
. 2016 Sep;
91(2):322-327.
PMID: 27623744
The aim of the study was to evaluate the impact of a regional population-based genetic testing program on the incidence of ovarian cancer in West Pomerania. Between 1999 and 2010,...
3.
Cybulski C, Wokolorczyk D, Kluzniak W, Kashyap A, Golab A, Slojewski M, et al.
Br J Cancer
. 2013 Jun;
108(12):2601-9.
PMID: 23722471
Background: To evaluate whether genotyping for 18 prostate cancer founder variants is helpful in identifying high-risk individuals and for determining optimal screening regimens. Methods: A serum PSA level was measured...
4.
Jakubowska A, Rozkrut D, Antoniou A, Hamann U, Scott R, McGuffog L, et al.
Br J Cancer
. 2012 Jun;
106(12):2016-24.
PMID: 22669161
Background: The variable penetrance of breast cancer in BRCA1/2 mutation carriers suggests that other genetic or environmental factors modify breast cancer risk. Two genes of special interest are prohibitin (PHB)...
5.
Gronwald J, Huzarski T, Byrski B, Medrek K, Menkiszak J, Monteiro A, et al.
J Med Genet
. 2005 Oct;
43(5):424-8.
PMID: 16227521
Background: Mutations in the BRCA1 (MIM 113705) gene are found in many families with multiple cases of breast and ovarian cancer, and women with a BRCA1 mutation are at significantly...
6.
Gorski B, Menkiszak J, Gronwald J, Lubinski J, Narod S
J Med Genet
. 2004 Dec;
41(12):e130.
PMID: 15591272
No abstract available.
7.
Menkiszak J, Gronwald J, Gorski B, Byrski T, Huzarski T, Jakubowska A, et al.
Eur J Gynaecol Oncol
. 2004 Apr;
25(1):99-100.
PMID: 15053073
Purpose Of Investigation: The purpose of the present study was to identify the clinical and pathologic features of ovarian cancers in patients who have a family history of breast or...
8.
Menkiszak J, Rzepka-Gorska I, Gorski B, Gronwald J, Byrski T, Huzarski T, et al.
Eur J Gynaecol Oncol
. 2004 Apr;
25(1):93-5.
PMID: 15053071
Currently genetic testing for BRCA1 and BRCA2 susceptibility genes is performed throughout Europe and North America. In Poland three founder mutations in BRCA1 account for 14% of all invasive ovarian...
9.
Gronwald J, Gorski B, Byrski T, Huzarski T, Jakubowska A, Menkiszak J, et al.
J Med Genet
. 2003 Sep;
40(9):719-20.
PMID: 12960221
No abstract available.
10.
Jakubowska A, Gorski B, Byrski T, Huzarski T, Gronwald J, Menkiszak J, et al.
Hum Mutat
. 2001 Jul;
18(2):149-56.
PMID: 11462239
BRCA1 mutation detection is expensive and has sensitivity limitations, which might at least partially be overcome by RNA-based sequencing. There are claims that RNA tests are unreliable due to differential...